Propionic Acid

Propionic Acid

SCHEMBL263427

CCC(=O)O.CCOC(=O)c1cccc2c1Cc1ccccc1O2

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.48
ALDH1A1 P00352 4/20 0.43
HSD17B10 Q99714 2/20 0.43
TRPA1 O75762 2/20 0.41
CDC25B P30305 2/20 0.40
MAPT P10636 4/20 0.40
RAB9A P51151 3/20 0.40
GAA P10253 2/20 0.40
HPGD P15428 2/20 0.40
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40
GLA P06280 1/20 0.40
ATM Q13315 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
NPSR1 Q6W5P4 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ACSL1 P33121 1/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
USP2 O75604 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL899854 0.95 TSHR (0.53) TSHRALDH1A1HSD17B10TRPA1CDC25B
SCHEMBL447793 0.94 TSHR (0.51) TSHRALDH1A1HSD17B10TRPA1CDC25B
Calcium SCHEMBL8504089 0.94 TSHR (0.51) TSHRALDH1A1HSD17B10TRPA1CDC25B
Lithium SCHEMBL11047758 0.94 TSHR (0.51) TSHRALDH1A1HSD17B10TRPA1CDC25B
SCHEMBL9244736 0.94 TSHR (0.51) TSHRALDH1A1HSD17B10TRPA1CDC25B
Potassium SCHEMBL41206 0.94 TSHR (0.51) TSHRALDH1A1HSD17B10TRPA1CDC25B
SCHEMBL1175633 0.94 TSHR (0.51) TSHRALDH1A1HSD17B10TRPA1CDC25B
SCHEMBL16414281 0.94 TSHR (0.51) TSHRALDH1A1HSD17B10TRPA1CDC25B
SCHEMBL664364 0.85 ALDH1A1 (0.55) TSHRALDH1A1HSD17B10TRPA1KDM4E
Potassium SCHEMBL5865052 0.84 ALDH1A1 (0.54) TSHRALDH1A1HSD17B10TRPA1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2443482-B1 BIOMEDICAL DEVICES, POLYMERIC MATERIALS AND CONTACT LENSES COMPRISING THE SAME. BAUSCH & LOMB (US) 2017-03-01 EP claimed
US-20100315588-A1 Biomedical devices BAUSCH & LOMB INCORPORATED (US) 2010-12-16 US claimed
US-20260147141-A1 SURFACE MODIFIED SILICONE OPHTHALMIC DEVICES BAUSCH + LOMB IRELAND LIMITED (IE) 2026-05-28 US disclosed
US-20260078209-A1 SILICONE HYDROGEL INK BINDER FOR CONTACT LENSES BAUSCH & LOMB IRELAND LTD (IE) 2026-03-19 US disclosed
EP-4646240-A1 BIOMEDICAL DEVICES HAVING A SURFACE COATING Bausch + Lomb Ireland Limited (IE) 2025-11-12 EP disclosed
US-20250321364-A1 SURFACE MODIFIED OPHTHALMIC DEVICES BAUSCH & LOMB IRELAND LTD (IE) 2025-10-16 US disclosed
US-20240240047-A1 BIOMEDICAL DEVICES HAVING A SURFACE COATING JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT 2024-07-18 US disclosed
WO-2024146878-A1 BIOMEDICAL DEVICES HAVING A SURFACE COATING BAUSCH + LOMB IRELAND LIMITED (IE) 2024-07-11 WO disclosed
EP-3834018-A1 OPHTHALMIC DEVICES Bausch & Lomb Incorporated (US) 2021-06-16 EP disclosed
CN-112930487-A Ophthalmic device 鲍希与洛姆伯股份有限公司 2021-06-08 CN disclosed
US-10668676-B2 Ophthalmic devices BAUSCH & LOMB INCORPORATED (US) 2020-06-02 US disclosed
EP-2443485-A2 BIOMEDICAL DEVICES Bausch & Lomb Incorporated (US) 2012-04-25 EP disclosed
US-8133960-B2 Biomedical devices BAUSCH & LOMB INCORPORATED (US) 2012-03-13 US disclosed
US-8083348-B2 Biomedical devices BAUSCH & LOMB INCORPORATED (US) 2011-12-27 US disclosed
WO-2010147875-A2 BIOMEDICAL DEVICES BAUSCH & LOMB INCORPORATED (US) 2010-12-23 WO disclosed
WO-2010147864-A2 BIOMEDICAL DEVICES BAUSCH & LOMB INCORPORATED (US) 2010-12-23 WO disclosed
WO-2010147876-A2 BIOMEDICAL DEVICES BAUSCH & LOMB INCORPORATED (US) 2010-12-23 WO disclosed
US-20100317816-A1 Biomedical devices BAUSCH & LOMB INCORPORATED (US) 2010-12-16 US disclosed
US-20100317817-A1 Biomedical devices BAUSCH & LOMB INCORPORATED (US) 2010-12-16 US disclosed
US-20100315588-A1 Biomedical devices BAUSCH & LOMB INCORPORATED (US) 2010-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078209-A1 SILICONE HYDROGEL INK BINDER FOR CONTACT LENSES CRYAA, CRYAB, CRYZ TSHR 553/4885ALDH1A1 2751/4885HSD17B10 1846/4885
US-20260147141-A1 SURFACE MODIFIED SILICONE OPHTHALMIC DEVICES EPCAM, STIM1, SMCHD1 TSHR 1380/4885ALDH1A1 2187/4885HSD17B10 2474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.